TIAP and Evotec Expand LAB150 BRIDGE Partnership to Include Amgen
yahoo.com
news
2022-10-17 11:00:00

Amgen to Join LAB150 to Build Canada's Next Generation of Life Science Companies

TORONTO, Canada & HAMBURG, Germany, October 17, 2022--(BUSINESS WIRE)--Toronto Innovation Acceleration Partners ("TIAP") and Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced that the two companies have expanded LAB150, their translational BRIDGE partnership, to include Amgen as a strategic partner. The expansion goes along with a combined investment of US$14M to expedite LAB150 programs towards the formation of new companies.
